calibrate reds max

Product Overview

Calibrate Reds Max is formulated by eimele, an evidence-based nutraceutical brand combining patented phytonutrient complexes selected for their mechanistically distinct and complementary actions on carbohydrate, fat, and appetite pathways. The flagship ingredient, Reducose™ (Morus alba White Mulberry Leaf Extract standardised to 5% deoxynojirimycin, DNJ), is a patented, peer-reviewed alpha-glucosidase inhibitor. DNJ competitively inhibits the intestinal brush border enzyme alpha-glucosidase, slowing the hydrolysis of complex carbohydrates to monosaccharides and reducing the rate and magnitude of post-prandial glucose absorption — the same mechanism as the pharmaceutical compound acarbose, but derived from a botanical source. The 5% DNJ standardisation in Calibrate Reds Max delivers five times the active potency of standard 1% DNJ mulberry extracts.

The formulation's GLP-1 pathway contribution comes from trans-resveratrol (Vitis vinifera grape extract), which has been shown in cell-based and clinical research to extend the half-life of endogenous GLP-1 by inhibiting dipeptidyl peptidase-4 (DPP-4) activity, supporting appetite satiation signals and post-meal glycaemic control. The fat absorption pathway is addressed through Rosefit™ (Rosa multiflora Multiflora Rose extract) — a polyphenol and isoquercetin complex demonstrating pancreatic lipase inhibitory activity in published in vitro and clinical studies — and Morosil™ (Citrus sinensis Moro blood orange extract), whose anthocyanin profile, particularly cyanidin-3-glucoside, has been clinically studied for its capacity to reduce adipocyte lipid accumulation and visceral fat deposition in a 12-week human RCT.

Specifications

Key Applications and Indications

• Post-prandial glucose management: Reduction of the glycaemic impact of carbohydrate-containing meals via Reducose™ alpha-glucosidase inhibition; suitable for individuals with elevated fasting glucose, pre-diabetes, or metabolic syndrome seeking non-pharmaceutical glycaemic support
• Dietary fat absorption reduction: Rosefit™ pancreatic lipase inhibitory activity reduces the proportion of dietary triglycerides absorbed intestinally, lowering net caloric burden from fat-containing meals
• Appetite and GLP-1 pathway support: Trans-resveratrol DPP-4 inhibition sustains endogenous GLP-1 signalling, supporting post-meal satiety, reducing cravings, and stabilising inter-meal energy levels
• Visceral and stored fat reduction: Morosil™ clinical RCT data demonstrates significant reductions in body weight and waist circumference over 12 weeks, attributed to adipocyte lipid accumulation inhibition via cyanidin-3-glucoside
• Metabolic wellness programmes: Adjunctive supplement for structured weight management programmes, low-carbohydrate dietary interventions, or longevity medicine protocols targeting insulin sensitivity and adiposity markers

Frequently Asked Questions

Q: How does Calibrate Reds Max differ from standard GLP-1 medications like semaglutide?
A: Calibrate Reds Max is a dietary supplement, not a pharmaceutical GLP-1 receptor agonist. It works by inhibiting DPP-4 (the enzyme that degrades endogenous GLP-1) rather than acting as an exogenous GLP-1 agonist. The effect is therefore modulatory rather than pharmacological — extending the activity of naturally secreted GLP-1 in response to eating, rather than introducing supraphysiological GLP-1 receptor stimulation. It does not replicate the potency of semaglutide or liraglutide, but provides a complementary, lower-risk option for individuals seeking metabolic support through dietary supplementation.

Q: When should Calibrate Reds Max be taken relative to meals?
A: For optimal Reducose™ activity, the capsule should be taken just before or at the start of a carbohydrate-containing meal so that alpha-glucosidase inhibition is active during intestinal digestion. For fat absorption reduction via Rosefit™, pre-meal dosing is similarly recommended. Specific dosage instructions on the product label take precedence — follow the manufacturer's guidance on the current batch.

Q: Is this product suitable for people with diabetes who are on medication?
A: Individuals with type 2 diabetes taking metformin, sulfonylureas, GLP-1 agonists, or insulin should consult their endocrinologist or primary care physician before using Calibrate Reds Max. The alpha-glucosidase inhibitory and GLP-1 pathway effects of the formulation may augment the glycaemic effects of antidiabetic medications, potentially increasing the risk of hypoglycaemia in sensitive individuals. Calibrate Reds Max is not a substitute for prescribed antidiabetic therapy.

Q: Is Calibrate Reds Max available in Singapore and is it approved by HSA?
A: Calibrate Reds Max is distributed in Singapore through EMIS Asia. As a health supplement containing botanical extracts, it is regulated under the HSA Singapore Health Products Act as a health supplement and does not require individual product registration, provided it complies with HSA's compositional requirements for health supplement ingredients. All patented ingredients (Reducose™, Rosefit™, Morosil™) are Generally Recognised as Safe (GRAS) or have established safety dossiers. Consumers are advised to consult a healthcare professional before use.

Q: Can healthcare professionals or clinics purchase Calibrate Reds Max in bulk from EMIS Asia?
A: Yes. EMIS Asia supplies Calibrate Reds Max to Singapore integrative medicine clinics, metabolic health centres, corporate wellness programmes, and weight management practitioners on a B2B basis. Contact EMIS Asia for clinic pricing, minimum order quantities, and patient education materials.